Literature DB >> 20800586

Effects of anticoagulants on human plasma soluble corin levels measured by ELISA.

Ningzheng Dong1, Jing Dong, Peng Liu, Luyao Xu, Sengseng Shi, Qingyu Wu.   

Abstract

BACKGROUND: Recently, soluble corin was detected in human plasma. In patients with heart failure, plasma corin levels were lower than that of normal controls. In this study, we analyzed experimental conditions for measuring plasma or serum corin by an immunoassay.
METHODS: Serum and plasma corin levels were measured by ELISA. Effects of different anticoagulants (EDTA, heparin and sodium citrate) on plasma corin levels were examined.
RESULTS: Corin levels in serum were similar to that in plasma with heparin (950±305 vs. 929±301 pg/ml, n=40, p=0.73), but were significantly higher than those in plasma with sodium citrate (735±237 pg/ml, p<0.01) or EDTA (716±261 pg/ml, p<0.001). Native and recombinant human corin proteins were stable in human plasma with EDTA at 4°C or underwent freezing-and-thawing. In 348 healthy Chinese individuals, plasma corin levels ranged from 216 to 1663 pg/ml. The levels were higher in males than that in females (842±283 vs. 569±192 pg/ml, p<0.001).
CONCLUSION: Soluble corin was stable in plasma samples. Plasma soluble corin levels vary depending on anticoagulants used. Samples containing heparin had significantly higher levels of corin than that in samples with EDTA or sodium citrate.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800586      PMCID: PMC2952697          DOI: 10.1016/j.cca.2010.08.021

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  33 in total

Review 1.  Type II transmembrane serine proteases.

Authors:  Qingyu Wu
Journal:  Curr Top Dev Biol       Date:  2003       Impact factor: 4.897

Review 2.  Natriuretic peptides.

Authors:  E R Levin; D G Gardner; W K Samson
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

3.  Plasma corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure.

Authors:  Kevin Shrestha; Richard W Troughton; Allen G Borowski; Timothy G Yandle; A Mark Richards; Allen L Klein; W H Wilson Tang
Journal:  J Card Fail       Date:  2010-05-04       Impact factor: 5.712

4.  Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.

Authors:  W Yan; F Wu; J Morser; Q Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart.

Authors:  W Yan; N Sheng; M Seto; J Morser; Q Wu
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

Review 6.  Gene targeting in hemostasis. Hepsin.

Authors:  Q Wu
Journal:  Front Biosci       Date:  2001-02-01

7.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors:  Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

8.  Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin.

Authors:  Sabine Knappe; Faye Wu; Mary Rose Masikat; John Morser; Qingyu Wu
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

9.  Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide.

Authors:  Sabine Knappe; Faye Wu; Mary Rose Madlansacay; Qingyu Wu
Journal:  J Biol Chem       Date:  2004-06-10       Impact factor: 5.157

Review 10.  Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure.

Authors:  Alan H B Wu; Andrew Smith
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

View more
  15 in total

1.  Human corin isoforms with different cytoplasmic tails that alter cell surface targeting.

Authors:  Xiaofei Qi; Jingjing Jiang; Mingqing Zhu; Qingyu Wu
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Ectodomain shedding and autocleavage of the cardiac membrane protease corin.

Authors:  Jingjing Jiang; Shannon Wu; Wei Wang; Shenghan Chen; Jianhao Peng; Xiumei Zhang; Qingyu Wu
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

Review 3.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 4.  BNP molecular forms and processing by the cardiac serine protease corin.

Authors:  Tomoko Ichiki; Brenda K Huntley; John C Burnett
Journal:  Adv Clin Chem       Date:  2013       Impact factor: 5.394

5.  Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy.

Authors:  Yujie Cui; Wei Wang; Ningzheng Dong; Jinglei Lou; Dinesh Kumar Srinivasan; Weiwei Cheng; Xiaoyi Huang; Meng Liu; Chaodong Fang; Jianhao Peng; Shenghan Chen; Shannon Wu; Zhenzhen Liu; Liang Dong; Yiqing Zhou; Qingyu Wu
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

6.  Role of Corin in Blood Pressure Regulation in Normotensive and Hypertensive Pregnancy.

Authors:  Mark B Badrov; Sun Young Park; Jeung-Ki Yoo; Michinari Hieda; Yoshiyuki Okada; Sara S Jarvis; Abigail S Stickford; Stuart A Best; David B Nelson; Qi Fu
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

7.  Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes.

Authors:  Jianhao Peng; Jingjing Jiang; Wei Wang; Xiaofei Qi; Xue-Long Sun; Qingyu Wu
Journal:  Biochem Biophys Res Commun       Date:  2011-07-06       Impact factor: 3.575

8.  Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment.

Authors:  Ningzheng Dong; Chaodong Fang; Yizhi Jiang; Tiantian Zhou; Meng Liu; Jianping Zhou; Jianzhong Shen; Koichi Fukuda; Jun Qin; Qingyu Wu
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

Review 9.  Role of corin and atrial natriuretic peptide in preeclampsia.

Authors:  Y Zhou; Q Wu
Journal:  Placenta       Date:  2012-12-02       Impact factor: 3.481

10.  Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected].

Authors:  Ningzheng Dong; Tiantian Zhou; Yue Zhang; Meng Liu; Hui Li; Xiaoyi Huang; Zhenzhen Liu; Yi Wu; Koichi Fukuda; Jun Qin; Qingyu Wu
Journal:  J Biol Chem       Date:  2014-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.